1,766
Views
43
CrossRef citations to date
0
Altmetric
Research Article

LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis

, &
Pages 11-18 | Received 12 Oct 2019, Accepted 02 Dec 2019, Published online: 27 Dec 2019

References

  • Allender S, Scarborough PPeto V. European cardiovascular disease statistics. European Heart Network. 2008;3:11–35.
  • Boon RA, Dimmeler S. MicroRNAs in myocardial infarction. Nat Rev Cardiol. 2015;12(3):135.
  • Townsend N, Wilson L, Bhatnagar P, et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–3245.
  • Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017;376(21):2053–2064.
  • Zhang R, Xia LQ, Lu WW, et al. LncRNAs and cancer. Oncol Lett. 2016;12(2):1233–1239.
  • Zhang H, Yang F, Chen SJ, et al. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumor Biol. 2015;36(4):2947–2955.
  • Delás MJ, Hannon GJ. lncRNAs in development and disease: from functions to mechanisms. Open Biol. 2017;7(7):170121.
  • Koch L. Functional genomics: screening for lncRNA function. Nat Rev Genet. 2017;18(2):70.
  • Vausort M, Wagner DR, Devaux Y. Long noncoding RNAs in patients with acute myocardial infarction. Circ Res. 2014;115(7):668–677.
  • Micheletti R, Plaisance I, Abraham BJ, et al. The long noncoding RNA Wisper controls cardiac fibrosis and remodeling. Sci Transl Med. 2017;9(395):eaai9118.
  • Cai B, Ma W, Ding F, et al. The long noncoding RNA CAREL controls cardiac regeneration. J Am Coll Cardiol. 2018;72(5):534–550.
  • Hu H, Wu J, Li D, et al. Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction through miR-320-Pten axis. Biomed Pharmacother. 2018;106:738–746.
  • Wang K, Liu CY, Zhou LY, et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun. 2015;6:6779.
  • Zhou T, Qin G, Yang L, et al. LncRNA XIST regulates myocardial infarction by targeting miR-130a-3p. J Cell Physiol. 2019;234(6):8659–8667.
  • Guo GL, Sun LQ, Sun MH, et al. LncRNA SLC8A1-AS1 protects against myocardial damage through activation of cGMP-PKG signaling pathway by inhibiting SLC8A1 in mice models of myocardial infarction. J Cell Physiol. 2019;234(6):9019–9032.
  • Li X, Dai Y, Yan S, et al. Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction. Biochem Biophys Res Commun. 2017;491(4):1026–1033.
  • Liu CY, Zhang YH, Li RB, et al. LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. Nat Commun. 2018;9(1):29.
  • Zhang Y, Hou Y, Gao F, et al. lncRNA GAS5 regulates myocardial infarction by targeting the miR-525-5p/CALM2 axis. J Cell Biochem. 2019;120(11):18678–18688.
  • D’alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010;31(22):2765–2773.
  • Zampetaki A, Willeit P, Tilling L, et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012;60(4):290–299.
  • Bayoumi AS, Teoh JP, Aonuma T, et al. MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition[. Cardiovasc Res. 2017;113(13):1603–1614.
  • Chu X, Wang Y, Pang L, et al. miR-130 aggravates acute myocardial infarction-induced myocardial injury by targeting PPAR-?. J Cell Biochem. 2018;119(9):7235–7244.
  • Yu B, Zhao Y, Zhang H, et al. Inhibition of microRNA-143-3p attenuates myocardial hypertrophy by inhibiting inflammatory response. Cell Biol Int. 2018;42(11):1584–1593.
  • Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing miRNA–lncRNA interactions[M]//Long Non-Coding RNAs. New York, NY: Humana Press; 2016. p. 271–286.
  • Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochimica Et Biophysica Acta (Bba)-gene Regulatory Mechanisms. 2014;1839(11):1097–1109.
  • Abbate A, Santini D, Biondi-Zoccai GGL, et al. Cyclo-oxygenase-2 (COX-2) expression at the site of recent myocardial infarction: friend or foe?. Heart. 2004;90(4):440–443.
  • Saito T, Rodger IW, Shennib H, et al. Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor. Can J Physiol Pharmacol. 2003;81(2):114–119.